The GRASP Project was created to better understand the greater health burden on African American scleroderma patients so that current patient care can be improved. It also aims to discover contributing genetic factors.
The CONQUER Registry is the first nationwide longitudinal registry for scleroderma patients in the United States. Led by the SRF and a group of clinicians from twelve major academic centers, this potentially transformative endeavor was launched in 2013.
Based on a model first created over a decade ago to accelerate oncology drug development, CONQUEST is an international, multicenter, randomized, double-blind, placebo-controlled, phase 2 platform clinical trial, and is the first of its kind in rare autoimmune diseases.
Current Funded Projects
Each year, the SRF receives and evaluates many applications for projects aimed at all facets of scleroderma research. Our Scientific Advisory Board asks probing questions about every project’s ability to deliver insights, answer questions, or better target therapies before considering projects for future funding.
Past Funded Projects
The Scleroderma Research Foundation has a long history of supporting research. Here you can learn about older projects that we funded.
When evaluating research applications for funding, we consider the investigator’s potential contributions to the SRF research program with questions such as: does the investigator have the appropriate skills and background to accomplish the project goals? Will this investigator add to our community through collaboration and generous sharing of ideas or resources?